After CTO Treatment: The Medicines and Habits That Help Keep the Reopened Artery Open

The discharge folder is thicker than you expected. There is a card with a picture of a small metal scaffold, a list of medicines with unfamiliar names, and a leaflet about cardiac rehabilitation. The procedure that reopened an artery blocked for months, perhaps years, took most of an afternoon. Now you are home, the wrist is a little bruised, and the question that matters most is quietly forming: how do I stop this from closing again?

That question, after CTO PCI, keeping the artery open, is the right one to ask. A chronic total occlusion is a coronary artery that has been completely blocked for at least three months. Reopening it is technically demanding. Keeping it open is a longer, quieter project, and much of it happens in kitchens, on walks and at the pharmacy counter rather than in the catheterization lab.

This explainer walks through what the evidence actually supports: which medicines do the heavy lifting, why the first months carry the most risk, which habits change the trajectory of the disease, and which warning signs should never be waited out.

What a chronic total occlusion is, and why the follow-up matters as much as the procedure

A coronary artery narrows over years as cholesterol-rich plaque builds under its lining. Sometimes that plaque grows until the channel closes completely and stays closed. When a complete blockage has been present for three months or longer, cardiologists call it a chronic total occlusion, or CTO.

Many people with a CTO are alive and functioning because the heart has quietly built detours. Collateral vessels are small side branches that enlarge over time to carry blood around a blockage. They are rarely enough for a brisk walk uphill or a flight of stairs with shopping, which is why the classic story is tiredness, breathlessness or chest tightness on exertion that has crept up so slowly it feels like ageing.

Percutaneous coronary intervention, usually shortened to PCI, is the procedure in which a thin tube is passed through a blood vessel in the wrist or groin to the heart, a balloon is inflated to open the narrowing, and a stent, a tiny expandable metal mesh tube, is left behind to hold the artery open. According to the Mayo Clinic, most stents used today are drug-eluting, meaning they slowly release a medicine that limits the scar tissue that would otherwise regrow inside the mesh.

Here is the point that shapes everything that follows. The stent treats one segment of one artery. The disease that produced the blockage lives in the whole coronary tree, and the body treats the new metal surface as a wound until its own lining grows over it. Keeping the reopened artery open therefore means two separate jobs at once: protecting the stent while it heals, and slowing the underlying disease everywhere else. Medicines do the first job well. Medicines and habits together do the second.

How CTO PCI actually works, in plain language

A standard angioplasty threads a fine wire through a narrowed but open channel. In a CTO there is no channel, only a plug of old, often hardened plaque, sometimes with calcium as dense as bone. The operator has to create a path through or around it.

Three broad approaches exist. In the antegrade approach, the wire is advanced from the front, in the direction blood normally flows, using specialised stiff or tapered wires to probe for soft spots in the plaque. In the retrograde approach, the operator threads a wire backwards through one of the body’s own collateral channels, reaches the far side of the blockage, and works toward the front. Dissection and re-entry techniques deliberately pass the wire in the wall of the artery around the blockage and then re-enter the true channel beyond it. Many procedures combine more than one of these.

Once a wire is across, the rest resembles a conventional PCI: small balloons stretch the segment, sometimes a device shaves or cracks heavy calcium, and one or more stents are placed. Because CTO segments are long, it is common for the stented length to be considerably greater than in a routine case. That longer metal surface is one of the reasons the after-care is so emphasised.

Access is usually via the radial artery at the wrist, though CTO work sometimes requires two access points. Sedation is light; most people are awake and can speak with the team. Imaging inside the artery, using ultrasound or light-based scanning on a fine catheter, is often used to check that the stent is fully expanded and pressed against the wall, because an under-expanded stent is a known contributor to later re-narrowing.

None of this is surgery in the traditional sense. There is no incision in the chest and the heart keeps beating normally throughout.

Who is usually offered CTO PCI, and who is usually asked to wait

The clearest reason to open a CTO is symptoms that persist despite good medical treatment. If breathlessness or chest tightness on exertion is limiting daily life, and the blocked artery supplies a substantial area of heart muscle that is still alive, reopening it aims to relieve those symptoms. Heart teams also weigh how much viable muscle sits beyond the blockage, because restoring flow to muscle that has already scarred offers little.

People who are often asked to wait, or who are guided toward other options, include those whose symptoms are mild and well controlled on medicines, those in whom the muscle beyond the blockage has largely scarred, those with kidney function that makes a long contrast-heavy procedure risky, and those whose overall pattern of disease makes bypass surgery a more suitable route. Coronary artery bypass grafting is the operation in which a surgeon sews a vein or artery from elsewhere in the body onto the heart to carry blood around blockages; for some patterns of multi-vessel disease it remains the preferred approach.

Waiting is not the same as doing nothing. Optimal medical therapy, the combination of antiplatelet, statin, blood pressure and anti-angina medicines with structured risk-factor work, is the foundation for everyone with coronary disease, whether or not a procedure follows. Guidelines from major cardiology societies treat CTO PCI as a symptom-driven decision, and both the American and European guidance emphasise that the choice should come from a heart team discussion that includes the patient’s own priorities.

If you are reading this before a decision, the honest framing is this: the procedure can be worth the effort when it is expected to change how you feel and function. Whether it does depends partly on the blockage and partly on what happens in the months afterward, which is why the rest of this article exists.

How long does a CTO procedure take, and how long do people stay in hospital?

People are often surprised by the time involved. The NHS describes a routine coronary angioplasty as taking roughly 30 minutes to two hours. A CTO procedure is a different order of task, because the operator may need to try several wires and approaches before crossing the blockage. It is usual for these cases to be measured in hours rather than minutes, and the team will normally tell you in advance to expect a long session.

The longer time brings two practical considerations your team will monitor: the amount of X-ray contrast used, which matters for the kidneys, and the amount of radiation, which is why some centres schedule staged procedures rather than pressing on indefinitely in one sitting. Neither should worry you unduly if the team has planned for them, but it is reasonable to ask how they are managed.

Hospital stay is often shorter than people imagine. The NHS notes that after a planned angioplasty, most people go home the same day or the following day. After a CTO procedure, an overnight stay is common because of the length of the case and the access sites, though practice varies between teams and depends on how the procedure went, your kidney function and whether anything unexpected occurred.

Before discharge, expect a check of the wrist or groin site, a review of your kidney blood tests if contrast use was high, and a clear conversation about medicines. That conversation is the single most valuable part of the stay. If it feels rushed, ask for it to be repeated. You should leave knowing the names of your antiplatelet medicines, why there are two, and how long each is planned to continue.

After CTO PCI, keeping the artery open: what the first days and weeks usually look like

The first week is mostly about the access site and about starting habits. Expect a bruise at the wrist or groin, sometimes a walnut-sized lump under the skin that softens over a couple of weeks. Bleeding that soaks through a dressing, a rapidly growing swelling, or a hand that becomes cold or numb is not normal and needs same-day assessment.

Movement starts early. Walking on flat ground the day after discharge is usually encouraged; heavy lifting with the access arm and strenuous exercise are usually held back for a short period set by your team. The NHS suggests that after a planned angioplasty people can often return to work in around a week and, in the UK, may drive again after about a week, though driving rules differ by country and your own team’s advice takes precedence.

The first weeks to months are the window of highest risk for stent thrombosis, a sudden clot forming on the stent that can close the artery abruptly and cause a heart attack. This is the reason the antiplatelet medicines are non-negotiable in this period. The Mayo Clinic notes that the risk of a clot on a stent is highest early, before the artery’s own lining has grown over the struts.

Two things tend to happen emotionally around week two or three. Some people feel dramatically better, because muscle that had been starved of blood for years is finally supplied, and they are tempted to test their limits. Others feel oddly flat or anxious, aware of every twinge in the chest. Both are common. Mild, brief discomfort at the stent site can occur as the artery adapts, but new exertional chest pain, or pain that resembles the original symptoms, should be reported rather than reasoned away.

Your first outpatient review, typically within a few weeks, is where medicines are checked, side effects addressed and cardiac rehabilitation confirmed.

Dual antiplatelet therapy after stent: why two medicines, and why the timeline is not negotiable

Platelets are the small cell fragments that rush to any damaged surface in a blood vessel and stick together to form a plug. From the platelet’s point of view, a freshly placed stent is an injury to be sealed. Left unchecked, that sealing instinct can produce a clot large enough to block the artery.

Dual antiplatelet therapy, usually shortened to DAPT, means taking two medicines that dampen platelets by different mechanisms: aspirin, which blocks one activation pathway, and a P2Y12 inhibitor, a class that includes clopidogrel, prasugrel and ticagrelor, which blocks another. Using both gives more complete protection than either alone during the healing months.

The duration is set by your cardiologist and depends on the stent type, how much artery was stented, whether the procedure was done for a stable condition or after a heart attack, and your individual bleeding risk. The NHS states that after a drug-eluting stent the second antiplatelet is commonly continued for up to 12 months, and the Mayo Clinic notes that aspirin is often continued long term. Some people are advised on shorter or longer courses; that is a clinical judgement, not a sign that anything is wrong.

Three rules follow from the mechanism. First, never stop either medicine because of bruising, minor nosebleeds or an upcoming dental appointment without speaking to the prescribing team; most dental work can proceed on DAPT. Second, if another clinician suggests pausing them for an operation or endoscopy, ask that they contact your cardiologist first. Third, if you run short, treat it as urgent rather than as something to sort out next week.

DAPT does increase bleeding tendency. That is a known trade-off your team has weighed. Report black or bloody stools, blood in urine or bleeding that will not stop, but do not adjust the medicines yourself. If side effects are troublesome, the answer is usually a different agent or a review of the plan, decided with your cardiologist.

Statins and cholesterol: slowing the disease in the rest of the artery

If antiplatelets protect the stent, statins protect everything around it. Low-density lipoprotein cholesterol, often written LDL, is the particle that carries cholesterol into the artery wall and feeds plaque. Statins are a class of medicines that reduce the liver’s production of cholesterol and increase its removal of LDL from the blood.

The evidence here is among the strongest in cardiology. Lower LDL over years means slower plaque growth, and there is good evidence that plaques in people on high-intensity statin therapy become more stable and less likely to rupture. For someone who has just had a CTO opened, the practical meaning is simple: the artery that blocked once has other segments that could narrow, and the other two main arteries have plaque too. Statins act on all of them at once.

Guidelines set specific LDL targets for people with established coronary disease, and those targets are lower than for the general population. The exact number your team is aiming for, and how it will be measured, is worth asking about at the first review. If a statin alone does not reach the target, or causes intolerable muscle aches, other cholesterol-lowering classes exist, such as ezetimibe or injectable PCSK9 inhibitors, and the prescribing clinician will decide whether they are appropriate.

Two myths deserve early correction. Feeling well is not a reason to stop a statin; the medicine works on a process you cannot feel. And a normal cholesterol level on a statin is evidence that the statin is working, not that it is no longer needed. Blood tests are typically repeated a couple of months after any change and then periodically.

Diet still matters alongside the medicine. Replacing saturated fat with unsaturated fat, and increasing soluble fibre from oats, beans and vegetables, adds a modest further LDL reduction on top of what tablets achieve.

Blood pressure, blood sugar and the other medicines your team may discuss

Beyond antiplatelets and statins, several other medicine classes commonly appear on a post-PCI list. Each has a mechanism worth understanding, because understanding is what keeps people taking them.

Blood pressure medicines reduce the mechanical stress on artery walls. The American Heart Association classifies a reading of 130/80 mmHg or above as high blood pressure, and people with coronary disease are usually managed to below that threshold. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers relax vessels and protect the heart muscle, and are often chosen when the pumping function has been reduced or when diabetes or kidney disease is present.

Beta blockers slow the heart rate and reduce how hard the heart works, which lowers oxygen demand. They are common after a heart attack or when angina persists. Long-acting nitrates and other anti-angina medicines may be continued for a period after a CTO procedure, then reviewed as symptoms settle.

Blood sugar deserves special mention. Diabetes accelerates coronary disease and is linked with higher rates of re-narrowing inside stents. Good glucose control, together with the newer glucose-lowering classes that also carry cardiovascular benefit, is part of keeping the artery open, and your cardiologist and diabetes clinician may coordinate on this.

People often ask whether they really need everything on the list. The honest answer is that each medicine addresses a different mechanism of disease, and the combination is what the evidence supports. The right response to side effects, cost concerns or simple confusion is a medication review with the prescribing team, never quiet omission. Bring the actual boxes to appointments; it reveals duplications and gaps faster than any list.

Medicines and habits after CTO PCI at a glance

The table below summarises what each element does and roughly how long it typically stays in the picture. Timelines are typical ranges drawn from the referenced patient guidance, not promises, and your own plan is set by your cardiologist.

Element	What it does for the reopened artery	Typical timeframe	Who decides changes
Aspirin	Reduces platelet clumping on the stent and elsewhere	Often long term (Mayo Clinic)	Prescribing cardiologist
Second antiplatelet (P2Y12 inhibitor)	Blocks a second platelet pathway during stent healing	Commonly up to 12 months after a drug-eluting stent (NHS); individualised	Prescribing cardiologist
Statin	Lowers LDL, slows plaque growth, stabilises plaque	Long term	Prescribing clinician
Blood pressure medicines	Reduce wall stress and heart workload	Long term, adjusted to readings	Prescribing clinician
Stopping smoking	Removes the strongest modifiable driver of clotting and plaque	Immediately and permanently	You, with support
Physical activity	Improves blood pressure, glucose, lipids and vessel function	Build from week one; ongoing	You, guided by rehab
Cardiac rehabilitation	Supervised exercise, education, medicine adherence	Programmes commonly run over several weeks (NHS)	Referral from team
Follow-up review	Checks symptoms, side effects, risk factors	First visit usually within weeks, then periodic	Care team

Notice what the table does not contain: any single item that works alone. The antiplatelets carry the early risk; the statin and blood pressure control carry the years; the habits change the slope of the underlying disease. Dropping any one weakens the others.

Habits that protect a stented artery: smoking, movement, food, weight and sleep

Medicines cannot outrun a cigarette. Smoking makes platelets stickier, injures the artery lining and accelerates plaque, and it does all three within hours of each cigarette. Of every habit on this page, stopping smoking is the one with the largest effect on whether a reopened artery stays open. Nicotine replacement, prescription aids and structured support roughly double the chance of quitting compared with willpower alone, and none of them is off limits after a stent; ask your team which suits you.

Movement comes next. The American Heart Association recommends at least 150 minutes a week of moderate-intensity aerobic activity, or 75 minutes of vigorous activity, plus muscle-strengthening activity on two days. Moderate means you can talk but not sing. After a CTO procedure the sensible route to that target is gradual and supervised, which is exactly what cardiac rehabilitation provides. Regular activity lowers blood pressure, improves how the body handles glucose, raises protective HDL cholesterol and improves the artery lining’s ability to dilate.

Food is less about a named diet than a pattern: vegetables, fruit, whole grains, legumes, nuts, fish, olive oil, and less processed meat, refined carbohydrate and salt. This pattern is associated with fewer cardiovascular events in people who already have coronary disease, and it complements statins rather than replacing them.

Weight matters through its effects on blood pressure, glucose and lipids. If weight loss is part of your plan, it is a medical goal to be approached with support, not a moral test.

Sleep and alcohol are the quiet ones. Untreated sleep apnoea, in which breathing pauses repeatedly during sleep, raises blood pressure and strains the heart; loud snoring with daytime sleepiness is worth mentioning at review. Alcohol raises blood pressure and adds bleeding risk on antiplatelets, so staying within national low-risk limits is prudent.

Cardiac rehab after angioplasty: the most underused part of keeping the artery open

Cardiac rehabilitation is a structured programme of supervised exercise, education about heart disease and medicines, and support for changing habits, delivered by nurses, physiotherapists and other specialists over a series of sessions. The NHS describes it as a routine offer after angioplasty, and cardiology guidelines on both sides of the Atlantic recommend it for everyone after PCI.

Despite that, attendance is consistently lower than referral. People decline because they feel fine, because sessions clash with work, because they assume it is for older or sicker patients, or because nobody explained what it is. After a CTO procedure in particular, rehab solves a real problem: many patients have avoided exertion for years because it brought on symptoms, and they have lost both fitness and confidence. Rehearsing exercise in a monitored setting rebuilds both.

A typical programme starts with an assessment of what you can safely do, sets a personalised exercise prescription, and progresses over the weeks. Sessions usually include group education on medicines, diet, stress and warning signs, which is where many people finally understand why they take a statin. Home-based and digital programmes exist for those who cannot attend in person, and the evidence supports them as reasonable alternatives when supervised sessions are impractical.

Rehab also addresses mood. Low mood and anxiety are common after any cardiac procedure and are associated with poorer adherence to medicines. Programmes screen for both and can point you toward help.

If you have not been offered rehabilitation, ask. If you were offered it and declined, it is not too late to reconsider. Among all the things a person can do after CTO PCI to keep the artery open, completing a rehabilitation programme is the one that quietly bundles most of the others together.

How long do stents last, and how will my team check the artery is still open?

A stent does not wear out or need replacing. Once the artery’s own lining has grown over the struts, the metal becomes part of the vessel wall for life. What can happen is that the artery narrows again inside or at the edges of the stent. Cardiologists call this in-stent restenosis: a regrowth of scar-like tissue within the stented segment. Drug-eluting stents were designed to limit it, and the Mayo Clinic notes that the medicine coating reduces the chance of re-narrowing compared with older bare-metal designs.

Restenosis tends to appear, when it does, in the first year, and it usually announces itself gradually as returning exertional symptoms rather than as a sudden event. Stent thrombosis, the sudden clot described earlier, is a different and rarer problem, and is the one most closely linked to stopping antiplatelet medicines early.

Follow-up is mostly clinical. Your team will ask about symptoms, check blood pressure, review lipid and glucose results, and look at how you are managing the medicines. Routine repeat angiography in someone without symptoms is not standard practice, because it carries its own small risks and rarely changes management. If symptoms return, a stress test, a nuclear perfusion scan or a CT coronary angiogram may be used to look for reduced blood flow before deciding whether another invasive angiogram is warranted.

The practical implication is that you are part of the monitoring system. Symptoms that resemble the ones you had before the procedure, or a new pattern of chest tightness or breathlessness on effort, are the earliest signal most teams will get. Keeping a simple note of what brings on symptoms and how quickly they settle helps your cardiologist far more than a vague recollection at a six-month review.

What people often get wrong after CTO treatment

“The blockage is fixed, so the disease is fixed.” The stent treated a segment. Coronary artery disease is a whole-vessel, lifelong condition. The medicines and habits are what address it.

“I feel well, so I can ease off the tablets.” Antiplatelets and statins work on processes you cannot feel. Feeling well is the intended result, not a signal to stop. Stopping the second antiplatelet early is the most avoidable cause of stent thrombosis.

“A stent will last about ten years and then need replacing.” Stents are permanent. The artery may re-narrow, but the stent itself is not a component with a service life.

“PCI is heart surgery.” It is a catheter procedure done through a small puncture in the wrist or groin, usually under local anaesthetic. Bypass surgery is the operation that opens the chest. The two are different tools for different patterns of disease.

“Exercise is dangerous now that I have a stent.” The opposite is closer to the truth. Supervised, progressive exercise is recommended, and inactivity is a risk factor in its own right.

“Supplements can replace the statin.” No supplement has evidence comparable to statins for preventing coronary events. Some, including certain herbal products and high-dose fish oil preparations, can interact with antiplatelets. Tell your team about everything you take.

“If the procedure could not open the artery, nothing more can be done.” Not every CTO can be crossed. When that happens, medical therapy, cardiac rehabilitation, sometimes a second attempt with a different strategy, and in selected cases surgery remain options. The heart team decides which, with you.

“Bruising means the antiplatelets are too strong.” Easy bruising is expected. Only bleeding that will not stop, or blood in stools or urine, needs prompt review.

Questions to ask your care team before you go home and at your first review

The most useful appointments are the ones you arrive at with specific questions. These are the ones that tend to matter most after a CTO procedure.

• Which two antiplatelet medicines am I taking, and for how long is each planned to continue?
• What should I do if I miss a dose, run out, or another clinician suggests pausing them for a procedure?
• What LDL cholesterol level are you aiming for, and when will it be rechecked?
• What blood pressure and, if relevant, blood glucose readings are you aiming for?
• How much of the artery was stented, and does that change my follow-up plan?
• Was the stent expansion checked with imaging inside the artery?
• What symptoms would make you want to see me quickly, and how do I reach the team?
• Have I been referred to cardiac rehabilitation, and when does it start?
• What activity is reasonable this week, this month, and after rehabilitation?
• When can I drive, return to work and travel, given my own circumstances?
• Which of my other medicines, supplements or over-the-counter painkillers could interact with the antiplatelets?
• If this artery narrows again, what would the options be?

Write the answers down or ask permission to record them. If English is not your first language, ask for an interpreter; medicine instructions are not the place for guesswork. It also helps to bring one other person to the discharge conversation, because anxiety and sedation both erode memory.

Finally, ask who coordinates your care between the cardiology team and your family doctor. After the first few months, most of the work of keeping a reopened artery open happens in primary care, through blood pressure checks, lipid tests and prescription renewals. Knowing who owns that plan prevents medicines quietly lapsing when a repeat prescription is due.

When to call your doctor

Some symptoms after a CTO procedure need emergency services, not a phone call. Call your local emergency number immediately for chest pain, pressure or tightness that lasts more than a few minutes or comes and goes, particularly if it spreads to the arm, jaw, neck or back, is accompanied by sweating, nausea, breathlessness or light-headedness, or feels like the symptoms you had before the procedure but more severe. The Cleveland Clinic and MedlinePlus both list these as warning signs of a possible blocked stent or heart attack. Do not drive yourself.

Also treat as an emergency: bleeding from the access site that does not stop with firm pressure for ten minutes, a rapidly enlarging or very painful swelling at the wrist or groin, a hand or leg below the access site that becomes cold, pale, numb or weak, sudden severe headache, fainting, or vomiting or passing blood.

Contact your cardiology team or family doctor the same day for new or worsening breathlessness on effort, chest discomfort that is milder but new or recurring, a fast or irregular heartbeat you have not had before, fever or spreading redness at the puncture site, black stools, nosebleeds that keep returning, or any situation in which you have stopped or been told to stop an antiplatelet medicine.

Make a routine appointment, rather than waiting for the next scheduled review, for side effects that are making you reluctant to take a medicine, for persistent low mood or anxiety, for muscle aches you suspect are related to the statin, or for any planned dental work, operation or endoscopy so the antiplatelet plan can be agreed in advance.

When in doubt, call. Teams that place stents would far rather hear about a symptom that turns out to be nothing than learn of one after the fact.

Frequently asked questions

What is the success rate of CTO PCI?

Published success figures vary widely because they depend on how complex the blockage is, how it is measured and the experience of the operating team, so no single percentage applies to an individual. Success is usually defined as crossing the blockage and restoring flow with a stent in place. Your own cardiologist can give an estimate based on the features of your artery, and should also describe what happens if the attempt does not succeed.

Is PCI considered heart surgery?

No. PCI is a catheter procedure performed through a small puncture in the wrist or groin under local anaesthetic and light sedation, with the heart beating normally throughout. Heart surgery, such as coronary artery bypass grafting, involves opening the chest under general anaesthesia. The two are different treatments chosen for different patterns of coronary disease, and a heart team discussion decides which is more suitable.

How long does a CTO procedure take?

Longer than a routine angioplasty. The NHS describes a standard angioplasty as taking around 30 minutes to two hours; CTO procedures are usually measured in hours because the operator may need to try several wires and approaches to cross a long-standing blockage. Your team will warn you to expect a long session and will monitor contrast and radiation use throughout, sometimes choosing to stage the work over more than one visit.

How long do patients stay in hospital after PCI?

Often only briefly. The NHS notes that after a planned angioplasty most people go home the same day or the next day. After a CTO procedure an overnight stay is common because of the length of the case, the access sites and the need to check kidney function after a larger contrast load. The exact stay depends on how the procedure went and is decided by the treating team.

What is dual antiplatelet therapy after a stent and why do I need two medicines?

Dual antiplatelet therapy means taking aspirin together with a second medicine from the P2Y12 inhibitor class. Each blocks a different pathway by which platelets stick together, so the pair provides fuller protection against a clot forming on the new stent while the artery’s lining heals over it. The duration is individualised; the NHS describes the second medicine commonly continuing for up to 12 months after a drug-eluting stent.

How long do stents last?

Stents are permanent. Once the artery’s lining has grown over the mesh, the metal becomes part of the vessel wall and never needs replacing. What can change is the artery itself, which may narrow again inside or at the edges of the stent, usually within the first year and usually gradually. Drug-eluting stents release a medicine that reduces this re-narrowing compared with older designs, according to the Mayo Clinic.

What does life after a coronary stent look like day to day?

For most people it looks like ordinary life with a few fixed points: taking the prescribed medicines at the same time each day, moving regularly, eating a pattern rich in vegetables, whole grains and unsaturated fats, not smoking, and attending follow-up. Many people with a reopened CTO find they can do more than before because muscle that was short of blood is now supplied, which is exactly why cardiac rehabilitation matters.

Can I do cardiac rehab after angioplasty if I feel completely well?

Yes, and it is recommended regardless of how you feel. Cardiac rehabilitation combines supervised, progressive exercise with education on medicines, diet and warning signs, and it is advised after PCI by major cardiology guidelines. Feeling well is common after a CTO is reopened, but the underlying disease remains, and rehabilitation is where most people rebuild fitness safely and understand why each medicine is on the list.

What should I do if I run out of my antiplatelet medicine or a dentist asks me to stop it?

Treat running out as urgent and contact your pharmacy or prescriber the same day rather than waiting. If a dentist, surgeon or other clinician suggests pausing an antiplatelet, ask them to speak with your cardiologist before any change; most dental work can safely proceed without stopping these medicines. Stopping the second antiplatelet early is the most avoidable cause of a sudden clot on a stent.

Will I need another angiogram to check the stent is open?

Usually not unless symptoms return. Routine repeat angiography in someone who feels well is not standard practice because it carries small risks and rarely changes treatment. Follow-up is mostly clinical: symptoms, blood pressure, cholesterol and glucose results. If exertional symptoms come back, a stress test, perfusion scan or CT coronary angiogram is often used first to look for reduced blood flow before deciding on an invasive angiogram.

References

• NHS: Coronary angioplasty and stent insertion
• MedlinePlus: Angioplasty and stent placement – heart
• Cleveland Clinic: Percutaneous Coronary Intervention (PCI)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.